Clinical Trial Update: Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort [NA]

View source ↗

Summary

Completed genetic polymorphism study in children with Alpha-1 antitrypsin deficiency included in the DEFI-ALPHA cohort.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Children With a Deficiency of Alpha-1 Antitrypsin | NA | Status: COMPLETED